ArticleScientific reports2026
Ag-decorated Cu-doped ZnO nanomaterial for enhanced antibacterial application.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Differential Roles of Ag and ZnO in the Bactericidal Activity of Ag/ZnO-Hydroxyapatite Nanocomposites against Multidrug-Associated Methicillin-Resistant Staphylococcus aureus.Current microbiology · 2026Article
- Green synthesis and characterization of Ag and ZnO nanoparticles and Ag@ZnO nanocomposites usingRSC advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rapid emergence of antibiotic-resistant bacteria demands the development of efficient antimicrobial agents. Here, single ZnO, CuO, and Ag nanoparticles (NPs) and copper/silver-doped nanocomposites (NCs) with high porosity were prepared employing bottom-up combustion synthesis techniques. The better optoelectrical and charge transfer characteristics of modified NCs have been confirmed from the UV-vis-DRS, PL, and CV analysis. The inclusion of copper in the ZnO lattice causes a shift towards a high angle in the XRD pattern analysis. However, silver forms a separate crystal or aggregate with ZnO (ZnO/Ag) and enhances the charge transfer process through the interface. The XRD and HRTEM image analysis verified the development of Cu-ZnO/Ag/CuO NCs. The antibacterial activity was optimized by leveraging the synergistic effects of Ag, CuO, and ZnO and assessing the influence of calcination temperature. The bacterial deactivation ability of HSs NCs is significantly higher than that of bare ZnO, confirming the existence of a synergistic effect. The maximum zone of inhibition is found to be 22 mm on S. pyogenes bacteria. Here, the developed Cu-ZnO/Ag/CuO heterostructures (HSs) have been found to be a promising material for antibacterial activities. Thus, the synthesized materials have excellent future outlooks in large-scale real-life biomedical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.